Agile Therapeutics to Present at Upcoming Investor Conferences
Details of Agile’s presentations are as follows:
Event: 21st Annual
Location: Lotte New York Palace,
To access the live and archived webcasts of the presentations, visit the Investor Relations section of the Agile Therapeutics website at www.agiletherapeutics.com. The webcast will be archived on the Agile Therapeutics website for 60 days following the event.
About Agile Therapeutics, Inc.
Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our lead product candidate, Twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Contact: Investor Relations -- 609-683-1880
Source: Agile Therapeutics, Inc.